Education library
Answers, explained plainly.
Chest & Sleep publishes new articles every week — plain-language guides for patients, and clinical briefs for referring providers.
Four Pillars in the First Hour — and Four Orders to Skip
Oral beats IV. MDI-plus-spacer matches the nebulizer. And four things not to order.
October 29, 2026
The Patient Who Looks Fine at PEF 45%
Why symptoms lag behind airflow in the patients you can least afford to misjudge
October 22, 2026
What Happens When You Refer
The specialist path, start to finish, so the referral is a known quantity
October 15, 2026
Every Prednisone Prescription Has a Receipt
The toxicity is cumulative, and it starts lower than most of us assume
October 8, 2026
The Two Numbers That Pick the Drug
Phenotyping is what makes biologic selection something other than guesswork
October 1, 2026
Before You Call It Severe
The five-step check that reclassifies most of these patients
September 24, 2026
Severe Asthma 2026: The CHEST Framework for Choosing — and Switching — Biologics
Asthma pharmacotherapy, part 4 of 4: the five pre-biologic checks, the CHEST 2026 selection framework, and the 4–6-month response review.
August 27, 2026
Beyond ICS-LABA: When to Add Tiotropium, and How to Weigh Montelukast After the Boxed Warning
Asthma pharmacotherapy, part 3 of 4: where LAMA fits in the ladder, and how the March 2020 boxed warning reshaped montelukast prescribing.
August 20, 2026
One Inhaler, Both Jobs: MART and the End of SABA-Only Care
Asthma pharmacotherapy, part 2 of 4: MART cuts severe exacerbations 32–41%, the 2025 JAMA meta-analysis, and why the SABA refill history is a vital sign.
August 13, 2026
The Stepwise Approach: Low-Dose ICS Does 80–90% of the Work
Asthma pharmacotherapy, part 1 of 4: severity sets the initial step, control scores drive everything after — and low-dose ICS delivers most of the obtainable benefit.
August 6, 2026
What Happens When You Refer: The 7-Day Path From Referral to Findings Note
The concrete path — referral, home sleep test, read, findings note back in your chart in about a week — so you can refer with confidence.
July 29, 2026
A-fib + Type 2 Diabetes + Weight: The Cluster That Points to the Sleep Lab
These three conditions travel with OSA — and when they stack up in one patient, the cluster itself is the referral trigger.
July 22, 2026
The Always-Exhausted Patient: When Fatigue Is Sleep Apnea in Disguise
Daytime sleepiness is the cardinal — and most missed — sign of OSA. How the ESS and one bed-partner question turn 'just tired' into a testable diagnosis.
July 15, 2026
Resistant Hypertension: The 3-Question Screen Before the Fourth BP Med
OSA is the most common identifiable contributor to resistant hypertension — the 30-second screen worth running before adding another agent.
July 8, 2026
COPD Pharmacotherapy in the GOLD 2026 Era: The Eosinophil-Guided Algorithm and the New Agents
A clinical brief on GOLD 2026 COPD pharmacotherapy — initial therapy by group, eosinophil-guided ICS decisions, and escalation beyond triple therapy.
May 22, 2026
Get new articles
One short email when we publish.
Patient guides and provider briefs. Unsubscribe any time.